10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001628280-23-036378`
Period End Date	20230930
Filing Date	20231102
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	agl-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 100 Cash Flow Statement 52 Stockholders Equity 42 Comprehensive Income 24

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$497.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$168.34M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.20M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.61M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$411.90M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$395.88M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$1.35B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$497.57M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$36.51M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$34.12M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.96B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	412.38M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.45B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	405.98M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$26.20M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$20.05M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	405.98M	shares	Point-in-time
Assets	`Assets`	$2.28B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$67.68M	USD	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$92.66M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Goodwill	`Goodwill`	$62.39M	USD	Point-in-time
Liabilities	`Liabilities`	$1.41B	USD	Point-in-time
Liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$116.92M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$140.18M	USD	Point-in-time
Total assets	`Assets`	$2.28B	USD	Point-in-time
Total assets	`Assets`	$1.70B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.01B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$346.73M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$183.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$290.56M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$535.09M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$34.78M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$38.48M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$70.37M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$83.29M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.41B	USD	Point-in-time
Total liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: $2,000,000 shares authorized; 405,980 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.12M	USD	Point-in-time
Common stock, $0.01 par value: $2,000,000 shares authorized; 405,980 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.97B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.11B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.10B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.23M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$872.37M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.04B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-767.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-611.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$871.60M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$879.45M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Total liabilities and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$2.28B	USD	Point-in-time
Total liabilities and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$53.98M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$20.74M	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$18.43M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$7.91M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.02B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$694.86M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.50B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.22B	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $20,736, $7,907, $53,980 and $18,430, respectively)	`GeneralAndAdministrativeExpense`	$51.98M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $20,736, $7,907, $53,980 and $18,430, respectively)	`GeneralAndAdministrativeExpense`	$222.48M	USD	3 Qtrs
General and administrative (including noncash stock-based compensation expense of $20,736, $7,907, $53,980 and $18,430, respectively)	`GeneralAndAdministrativeExpense`	$74.14M	USD	1 Quarter
General and administrative (including noncash stock-based compensation expense of $20,736, $7,907, $53,980 and $18,430, respectively)	`GeneralAndAdministrativeExpense`	$143.74M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$15.01M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.31M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.45M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$9.87M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$1.26B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$724.38M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$2.07B	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$3.57B	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-48.97M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-29.52M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-72.53M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-51.31M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.47M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$14.66M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$24.51M	USD	3 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$4.89M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$6.37M	USD	3 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$21.00M	USD	3 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$5.69M	USD	1 Quarter
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	3 Qtrs
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	$-5.46M	USD	3 Qtrs
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	1 Quarter
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$4.77M	USD	3 Qtrs
Interest expense	`InterestExpense`	$2.82M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.65M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.94M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-49.75M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.27M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.80M	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$524.00K	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$1.21M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$559.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$1.07M	USD	3 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-31.48M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-32.32M	USD	3 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-50.81M	USD	3 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-30.50M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$526.00K	USD	3 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	3 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-224.00K	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$26.00K	USD	3 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$12.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	3 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-236.00K	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	3 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$500.00K	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-32.32M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-31.48M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-50.31M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-30.74M	USD	1 Quarter
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.00K	USD	1 Quarter
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-156.00K	USD	3 Qtrs
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-228.00K	USD	3 Qtrs
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-71.00K	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-30.67M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-31.44M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-32.16M	USD	3 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-50.09M	USD	3 Qtrs
Continuing operations, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	1 Quarter
Continuing operations, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.08	USD	1 Quarter
Continuing operations, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.08	USD	3 Qtrs
Continuing operations, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.12	USD	3 Qtrs
Continuing operations, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.08	USD	1 Quarter
Continuing operations, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.08	USD	3 Qtrs
Continuing operations, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.12	USD	3 Qtrs
Continuing operations, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	1 Quarter
Discontinued operations, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Discontinued operations, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operations, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	3 Qtrs
Discontinued operations, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Discontinued operations, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Discontinued operations, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	3 Qtrs
Discontinued operations, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Discontinued operations, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	411.06M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	412.08M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	405.79M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	406.82M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	411.06M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	405.79M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	406.82M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	412.08M	shares	3 Qtrs

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-32.32M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-31.48M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-50.31M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-30.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.87M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.01M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$53.98M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$18.43M	USD	3 Qtrs
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.47M	USD	3 Qtrs
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$14.66M	USD	1 Quarter
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$24.51M	USD	3 Qtrs
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	1 Quarter
Other noncash items	`OtherNoncashIncomeExpense`	$-4.26M	USD	3 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$1.51M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$59.62M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$105.69M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-95.03M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.85M	USD	3 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.94M	USD	3 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.90M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$12.41M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$3.54M	USD	3 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$4.51M	USD	3 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$8.78M	USD	3 Qtrs
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	$423.18M	USD	3 Qtrs
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	$107.02M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$133.89M	USD	3 Qtrs
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$15.13M	USD	3 Qtrs
Net cash paid in business combination	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Net cash paid in business combination	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$44.48M	USD	3 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	3 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$500.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-436.42M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-41.82M	USD	3 Qtrs
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$11.46M	USD	3 Qtrs
Proceeds from equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$30.68M	USD	3 Qtrs
Common stock repurchase	`PaymentsForRepurchaseOfCommonStock`	$200.00M	USD	3 Qtrs
Common stock repurchase	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.75M	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$3.75M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-192.29M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$26.93M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-329.14M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-490.34M	USD	3 Qtrs
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$564.48M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.54M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$564.48M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.54M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	405.98M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$871.60M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$879.45M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-32.32M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-31.48M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-50.31M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-30.74M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.61M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-670.00K	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.10M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$139.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$31.46M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.27M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$10.39M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.72M	USD	1 Quarter
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	3 Qtrs
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	3 Qtrs
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$786.00K	USD	3 Qtrs
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$63.00K	USD	1 Quarter
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.81M	USD	3 Qtrs
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$28.00K	USD	1 Quarter
Common stock repurchase	`APICStockRepurchasedDuringPeriodNetOfTaxAdjustment`	$102.00K	USD	1 Quarter
Common stock repurchase	`StockRepurchasedDuringPeriodValue`	$201.46M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.91M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$53.98M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.43M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.74M	USD	1 Quarter
Ending balance, (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Ending balance, (in shares)	`CommonStockSharesOutstanding`	405.98M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$871.60M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$879.45M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-32.32M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-31.48M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-50.31M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-30.74M	USD	1 Quarter
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.61M	USD	1 Quarter
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-5.10M	USD	3 Qtrs
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-758.00K	USD	3 Qtrs
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$114.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$88.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$25.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-31.34M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-32.99M	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-36.35M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-55.41M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-47.00K	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-228.00K	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-71.00K	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-156.00K	USD	3 Qtrs
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-31.30M	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-36.28M	USD	1 Quarter
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-32.83M	USD	3 Qtrs
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-55.19M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.